ELISA detection of SARS-CoV-2 antibodies in saliva.
Sci Rep
; 10(1): 20818, 2020 11 30.
Article
in En
| MEDLINE
| ID: mdl-33257702
ABSTRACT
To facilitate containment of the COVID-19 pandemic currently active in the United States and across the world, options for easy, non-invasive antibody testing are required. Here we have adapted a commercially available, serum-based enzyme-linked immunosorbent assay (ELISA) for use with saliva samples, achieving 84.2% sensitivity and 100% specificity in a set of 149 clinical samples. This strategy will enable widespread, affordable testing for patients who experienced this disease, whilst minimizing exposure risk for healthcare workers.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Saliva
/
Enzyme-Linked Immunosorbent Assay
/
COVID-19 Serological Testing
/
COVID-19
/
Antibodies, Viral
Type of study:
Diagnostic_studies
Language:
En
Journal:
Sci Rep
Year:
2020
Type:
Article
Affiliation country:
United States